PWAM
MYGN icon

Private Wealth Asset Management’s Myriad Genetics MYGN Stock Holding History

Private Wealth Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-116
Closed -$1.03K – 1195
2025
Q1 		$1.03K Buy
+116
New +$1.39K ﹤0.01% 882

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Private Wealth Asset Management's MYGN Position: Q2 2025 in Review

Private Wealth Asset Management sold out of Myriad Genetics (MYGN) in Q2 2025, closing a stake of 116 shares — an estimated $1.03K sold.

Private Wealth Asset Management first reported a position in MYGN in Q1 2025 and held it in 1 quarter. The position peaked at $1.03K in Q1 2025. 221 funds tracked by Wall St. Rank hold MYGN as of Q2 2025.

  • Private Wealth Asset Management reported no remaining Myriad Genetics position as of Q2 2025 after selling out during the quarter.
  • Private Wealth Asset Management sold 116 Myriad Genetics shares in Q2 2025, an estimated $1.03K.
  • Private Wealth Asset Management first reported a position in Myriad Genetics in Q1 2025 and held it in 1 quarter.
  • Private Wealth Asset Management's Myriad Genetics position peaked at $1.03K in Q1 2025.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2025.

Based on Private Wealth Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.